Skip to main content

Tim Schroeder

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Tim Schroeder

Tim Schroeder was last confirmed as Board Member at Inmune Bio, Inc. (INMB) in a filing dated May 29, 2024. Inmune Bio, Inc. reported in an 8-K filed June 17, 2026 that Tim Schroeder was appointed Director, effective June 16, 2026. Inmune Bio, Inc. reported in an 8-K filed June 10, 2025 that Tim Schroeder was appointed Director, effective June 10, 2025. Inmune Bio, Inc. reported in an 8-K filed June 1, 2023 that Tim Schroeder was appointed Director, effective June 1, 2023.

“Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified.”
Inmune Bio, Inc. Form 8-K, filed June 17, 2026 · Read the filing
“Stockholders elected each of the following nominees as directors to hold office until the next meeting of the Company's stockholders and until his or her successor is elected and qualified.”
Inmune Bio, Inc. Form 8-K, filed June 10, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Inmune Bio, Inc. (INMB)

    Board Member

    Proxy statement

    2016-01-01–2024-05-29

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.